BIOMAT Database Logo BIOMAT Database Logo

Methylprednisolone blood levels in cadaveric renal allograft recipients. 1978

R A Sells, and L Brookes, and P Basu, and D Whitemore

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

R A Sells, and L Brookes, and P Basu, and D Whitemore
Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients.
November 2006, Transplantation proceedings,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Rigid-dose regimen versus blood level-adjusted cyclosporine in elderly cadaveric renal allograft recipients.
April 1988, Transplantation proceedings,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipients.
June 1988, Transplantation proceedings,
R A Sells, and L Brookes, and P Basu, and D Whitemore
High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection.
January 1976, Nephron,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Characteristics of cadaveric renal allograft recipients developing chronic rejection.
January 1990, Annals of the Royal College of Surgeons of England,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Development of specific nonreactivity in human cadaveric renal allograft recipients.
May 1976, Tissue antigens,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Cyclosporine improves outcome in high-risk cadaveric renal allograft recipients.
October 1984, Transplantation proceedings,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
April 1995, Clinical transplantation,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Can uric acid blood levels in renal transplant recipients predict allograft outcome?
December 2021, Renal failure,
R A Sells, and L Brookes, and P Basu, and D Whitemore
Neopterin levels in long-term renal allograft recipients.
March 1985, Immunobiology,
Copied contents to your clipboard!